This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignee: Urodelia. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Daniel Ciocca and His Immunotherapy Patent.
Introduction
Daniel Ciocca is an inventor associated with Mendoza, Argentina. His patent work includes a medicament designed for treatment using immunotherapy, particularly autologous immunotherapy.
Latest Patents
Ciocca is credited with 1 patent: “Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous.” The invention describes a medicament containing a solid biocompatible support, preferably in powder form, onto which an active substance—such as biological material or biological molecules—is adsorbed or intended to be adsorbed. The support can purify the active substance, and the process is designed to avoid the need for a coupling agent.
The patent also describes preparing the medicament by bringing the support into contact with the active substance so that it adsorbs reversibly without denaturing. This approach is intended to preserve the substance’s properties for immunotherapy applications.
Career Highlights
Ciocca is associated with Urodelia and Daniel Ciocca. His patent reflects work on biocompatible materials and the preparation of medicaments for immunotherapy.
Collaborations
The supplied information identifies Patrick Frayssinet and Nicole Rouquet as Ciocca’s coworkers. Their connection to his patent work is not specified.
Conclusion
Daniel Ciocca’s recorded invention focuses on a biocompatible support for preparing immunotherapy medicaments, with an emphasis on reversible adsorption and preserving active substances without denaturation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile